Editas Medicine, Inc. (EDIT) Operating income 2016–2025
Editas Medicine, Inc. (EDIT) annual operating income history from SEC filings — each fiscal year as reported.
-$160.0MFY2025 · since FY2016: -$97.2M → -$160.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.0M | +36.3% |
| FY2024 | -$251.2M | -48.5% |
| FY2023 | -$169.2M | +25.1% |
| FY2022 | -$225.9M | -17.0% |
| FY2021 | -$193.1M | -43.2% |
| FY2020 | -$134.8M | +4.3% |
| FY2019 | -$140.9M | -23.9% |
| FY2018 | -$113.7M | +5.2% |
| FY2017 | -$119.9M | -23.4% |
| FY2016 | -$97.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice